| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |